Spruce Biosciences, Inc.
SPRB
$55.11
$2.344.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.27M | -14.65M | -8.21M | -2.07M | -14.04M |
| Total Depreciation and Amortization | 252.00K | 5.00K | 3.00K | 7.00K | 6.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 851.00K | 5.78M | 585.00K | -472.00K | 451.00K |
| Change in Net Operating Assets | 2.43M | 2.41M | 2.31M | -6.30M | 857.00K |
| Cash from Operations | -8.73M | -6.46M | -5.32M | -8.83M | -12.73M |
| Capital Expenditure | -10.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10.00K | -- | -- | -- | -- |
| Total Debt Issued | 14.15M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -841.00K | -405.00K | -406.00K | -405.00K |
| Issuance of Common Stock | -- | 50.07M | 3.00K | -- | -- |
| Repurchase of Common Stock | -10.00K | -831.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.00K | -3.70M | -- | 6.00K | -6.00K |
| Cash from Financing | 13.92M | 44.69M | -402.00K | -400.00K | -411.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.17M | 38.24M | -5.72M | -9.23M | -13.14M |